A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.
The innate immune system employs Toll-like receptors (TLRs) for the detection of invading microorganisms based on distinct molecular patterns. For example, TLR9 is activated by microbial DNA and also by short therapeutic CpG-containing oligonucleotides (CpG-ODN). TLR9 activation leads to the product...
मुख्य लेखकों: | Kubarenko, A, Ranjan, S, Rautanen, A, Mills, T, Wong, S, Vannberg, F, Neumaier, M, Bekeredjian-Ding, I, Hill, A, Ahmad-Nejad, P, Weber, A |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2010
|
समान संसाधन
-
Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9
द्वारा: Avalos, Ana M., और अन्य
प्रकाशित: (2014) -
MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
द्वारा: George, J, और अन्य
प्रकाशित: (2010) -
Immunotherapeutic Potential of CpG Oligonucleotides in Chickens
द्वारा: Arshud Dar, और अन्य
प्रकाशित: (2009-04-01) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
द्वारा: Hidekazu Shirota, और अन्य
प्रकाशित: (2015-05-01) -
Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
द्वारा: Tokuyuki Yoshida, और अन्य
प्रकाशित: (2024-05-01)